1. Home
  2. DYN vs PLAB Comparison

DYN vs PLAB Comparison

Compare DYN & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • PLAB
  • Stock Information
  • Founded
  • DYN 1984
  • PLAB 1969
  • Country
  • DYN United States
  • PLAB United States
  • Employees
  • DYN N/A
  • PLAB N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • PLAB Semiconductors
  • Sector
  • DYN Health Care
  • PLAB Technology
  • Exchange
  • DYN Nasdaq
  • PLAB Nasdaq
  • Market Cap
  • DYN 1.2B
  • PLAB 1.2B
  • IPO Year
  • DYN 2020
  • PLAB 1987
  • Fundamental
  • Price
  • DYN $9.38
  • PLAB $19.53
  • Analyst Decision
  • DYN Strong Buy
  • PLAB Strong Buy
  • Analyst Count
  • DYN 15
  • PLAB 2
  • Target Price
  • DYN $43.07
  • PLAB $31.00
  • AVG Volume (30 Days)
  • DYN 3.3M
  • PLAB 497.5K
  • Earning Date
  • DYN 08-11-2025
  • PLAB 08-28-2025
  • Dividend Yield
  • DYN N/A
  • PLAB N/A
  • EPS Growth
  • DYN N/A
  • PLAB N/A
  • EPS
  • DYN N/A
  • PLAB 1.93
  • Revenue
  • DYN N/A
  • PLAB $856,742,000.00
  • Revenue This Year
  • DYN N/A
  • PLAB N/A
  • Revenue Next Year
  • DYN N/A
  • PLAB $5.06
  • P/E Ratio
  • DYN N/A
  • PLAB $10.11
  • Revenue Growth
  • DYN N/A
  • PLAB N/A
  • 52 Week Low
  • DYN $6.36
  • PLAB $16.46
  • 52 Week High
  • DYN $47.45
  • PLAB $31.60
  • Technical
  • Relative Strength Index (RSI)
  • DYN 45.89
  • PLAB 53.24
  • Support Level
  • DYN $8.95
  • PLAB $18.61
  • Resistance Level
  • DYN $9.83
  • PLAB $19.75
  • Average True Range (ATR)
  • DYN 0.55
  • PLAB 0.54
  • MACD
  • DYN 0.17
  • PLAB -0.03
  • Stochastic Oscillator
  • DYN 74.58
  • PLAB 50.55

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

Share on Social Networks: